D Ramsoekh

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi [Reactivation of hepatitis B infection due to glucocorticoids]
    Dewkoemar Ramsoekh
    Erasmus MC, afd Maag, Darm en Leverziekten, Rotterdam, The Netherlands
    Ned Tijdschr Geneeskd 155:A3710. 2011
  2. ncbi Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
    Dewkoemar Ramsoekh
    Department of Gastroenterology and Hepatology Erasmus MC University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    Hered Cancer Clin Pract 7:17. 2009
  3. ncbi The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Clin Genet 72:562-7. 2007
  4. ncbi Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome)
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 26:101-11. 2007
  5. ncbi A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
    D Ramsoekh
    Erasmus MC University Medical Center, s Gravendijkwal 230, 3015CE Rotterdam, The Netherlands
    Gut 57:1539-44. 2008
  6. ncbi Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting
    D Ramsoekh
    Department of Gastroenterology and Hepatology and Department of Public Health, Erasmus MC University Medical Center, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    J Med Genet 46:745-51. 2009
  7. ncbi Population screening for colorectal cancer: faeces, endoscopes or X-rays?
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Cell Oncol 29:185-94. 2007

Detail Information

Publications7

  1. ncbi [Reactivation of hepatitis B infection due to glucocorticoids]
    Dewkoemar Ramsoekh
    Erasmus MC, afd Maag, Darm en Leverziekten, Rotterdam, The Netherlands
    Ned Tijdschr Geneeskd 155:A3710. 2011
    ..Neither patient had received preventive antiviral therapy. In patients with chronic hepatitis B infection, preventive antiviral therapy should be started before treatment with glucocorticoids is initiated...
  2. ncbi Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management
    Dewkoemar Ramsoekh
    Department of Gastroenterology and Hepatology Erasmus MC University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    Hered Cancer Clin Pract 7:17. 2009
    ..The risk is dependent of the affected mismatch repair gene. The aim of the present study was to calculate the cumulative risk of LS related cancers in proven MLH1, MSH2 and MSH6 mutation carriers...
  3. ncbi The use of genetic testing in hereditary colorectal cancer syndromes: genetic testing in HNPCC, (A)FAP and MAP
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Clin Genet 72:562-7. 2007
    ..Moreover, time trend analysis showed a decline in test rate in HNPCC families. Studies evaluating the reasons for not testing are needed. Furthermore, a better implementation of genetic testing in clinical practice is desirable...
  4. ncbi Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome)
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Aliment Pharmacol Ther 26:101-11. 2007
    ..The most common hereditary colorectal cancer syndrome is hereditary non-polyposis colorectal cancer (HNPCC), also known as Lynch syndrome. Diagnosis of this syndrome is difficult, because of lack of specific diagnostic features...
  5. ncbi A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
    D Ramsoekh
    Erasmus MC University Medical Center, s Gravendijkwal 230, 3015CE Rotterdam, The Netherlands
    Gut 57:1539-44. 2008
    ..The aim of the present study was to evaluate the contribution of MSH6 gene mutations in families that were analysed for Lynch syndrome in a diagnostic setting...
  6. ncbi Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting
    D Ramsoekh
    Department of Gastroenterology and Hepatology and Department of Public Health, Erasmus MC University Medical Center, s Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands
    J Med Genet 46:745-51. 2009
    ..Prediction models have therefore been developed, but they have not been validated for a clinical genetic setting. The aim of the present study was to evaluate the usefulness of currently available prediction models...
  7. ncbi Population screening for colorectal cancer: faeces, endoscopes or X-rays?
    D Ramsoekh
    Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
    Cell Oncol 29:185-94. 2007
    ..In Europe, faecal occult blood testing and flexible sigmoidoscopy are currently the most suitable screening modalities for colorectal cancer screening...